logo-loader
viewTissue Regenix Group PLC

Tissue Regenix appoints interim finance chief Barker to full-time role

The regenerative medical devices specialist said Mike Barker will join the board with immediate effect having held the role on an interim basis since the start of the year

Tissue Regenix Group PLC -
A chartered accountant, Barker spent 10 years in corporate finance advisory working on private equity transactions before setting up his own consultancy that counselled small and mid-sized companies

Tissue Regenix Group (LON:TRX) has appointed a new chief financial officer.

The regenerative medical devices specialist said Mike Barker will join the board with immediate effect having held the role on an interim basis since the start of the year.

A chartered accountant, Barker spent 10 years in corporate finance advisory, working on private equity transactions, before setting up his own consultancy that counselled small and mid-sized companies.

He has also worked closely with the management team of Quantum Pharma, the manufacturer bought by Clinigen two years ago, and held the position of corporate development director there.

Chairman John Samuel said of Barker: "His experience in AIM-listed businesses and contribution to strategic planning will augment and strengthen our management and executive teams as we continue to improve the efficiency of our operations across the business to meet the increasing demand for our products."

Quick facts: Tissue Regenix Group PLC

Price: 1.225 GBX

AIM:TRX
Market: AIM
Market Cap: £14.36 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Tissue Regenix Group PLC named herein, including the promotion by the Company of Tissue Regenix Group PLC in any Content on the Site, the...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Tissue Regenix increasing throughput in its facility to meet 'exceptional...

Tissue Regenix PLC's (LON:TRX) Gareth Jones caught up with Proactive's Andrew Scott to update on developments in the regenerative medical devices maker's second half. ''The focus is really on increasing throughput in our San Antonia facility in the United States to allow us to meet the demand...

on 19/12/19

2 min read